LAGOS, Nigeria(VOICE OF NAIJA)- The Ebola outbreak in the Democratic Republic of the Congo (DRC) has become the second-largest on record, with 4,449 confirmed cases and 2,061 deaths reported across five provinces, according to the World Health Organization (WHO).
WHO Director-General Tedros Ghebreyesus said the outbreak was on course to surpass the 2014–2016 West African Ebola epidemic, which remains the largest recorded outbreak, with more than 28,000 cases and 11,000 deaths.
The current outbreak has recorded 4,449 confirmed cases and 2,061 deaths across five provinces and 53 health zones.
About 90 percent of cases and 80 percent of deaths are in Ituri Province, where transmission remains active in several areas.
Ghebreyesus reported that one of the biggest concerns was that many cases and deaths were being identified in communities rather than treatment centres, including among people who were not on known contact lists.
“That tells us there are chains of transmission we don’t know about, and until we know about – and break – every chain of transmission, we will not stop the outbreak,” he said.
He explained that Ebola transmission often occurs when patients are seriously ill but are not receiving treatment, or when bodies are handled after death.
He therefore stressed the importance of early treatment, safe burials and community cooperation.
The DRC government declared the outbreak on May 15, although health officials believe the virus may have been circulating for two to three months before it was detected.
The outbreak is caused by the Bundibugyo species of Ebola virus, a rare strain previously linked to outbreaks in Uganda in 2007–2008 and the DRC in 2012.
READ ALSO: Over 2,000 Ebola Death In Congo, Outbreak Cases Reach 4,381
Unlike the Zaire species, there is currently no licensed vaccine proven specifically to protect against Bundibugyo Ebola.
However, vaccine research is progressing.
WHO announced that two vaccines specifically designed against Bundibugyo virus have entered early human safety trials, while the organization has recommended further testing of the vaccine used against Zaire ebolavirus to determine whether it could provide protection against the Bundibugyo strain.
Notably, WHO and its partners are expanding the response, with a target of tracing at least 95 percent of contacts. Contact tracing is currently around 80 percent, according to Ghebreyesus.
Treatment capacity is also being expanded, with a target of 3,000 beds within 12 weeks.
More than 21,000 community health workers have been trained, while treatment centres, laboratories, safe burial teams and community engagement operations are active in affected areas.
So far, 886 patients have recovered from the disease. WHO stated that it hopes to bring transmission under control within three months, although this would not necessarily mean the immediate end of the outbreak.
The response continues to face major challenges, particularly insecurity and limited access in eastern DRC, where armed conflict has affected health operations.
WHO has also launched a clinical trial to assess potential treatments, with its PARTNERS study having reached 100 patients.
The scale and speed of the outbreak have increased pressure on health authorities to find hidden chains of transmission, expand treatment and strengthen community cooperation.
With new vaccines and treatments still under investigation, controlling the outbreak will depend heavily on early detection, safe care, contact tracing and sustained community participation.


